Related Experiment Video
Updated: May 9, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out
World Journal of Gastroenterology
|July 19, 2013
Summary
Chronic constipation may stem from an enteric neuropathic abnormality, not a functional disorder. Research shows decreased enteric glial cells and interstitial cells of Cajal in chronic constipation patients.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Pathophysiology
Background:
- Functional gastrointestinal disorders are increasingly linked to organic abnormalities, challenging previous psychosomatic models.
- Irritable bowel syndrome and functional dyspepsia show evidence of inflammation and immune activation.
- Esophageal achalasia involves abnormal neurotransmission and myenteric plexitis.
Discussion:
- Chronic constipation exhibits alterations in the enteric nervous system, including reduced enteric glial cells and interstitial cells of Cajal.
- These findings suggest a neuropathic basis for certain forms of chronic constipation.
- The traditional classification of chronic constipation as a functional disorder requires re-evaluation.
Key Insights:
- Chronic constipation is associated with a decrease in enteric glial cells and interstitial cells of Cajal.
- Evidence points towards an enteric neuropathic abnormality as a cause for chronic constipation.
- This challenges the long-held view of chronic constipation as a purely functional disorder.
Outlook:
- Reclassifying chronic constipation as an enteric neuropathic condition may lead to new diagnostic and therapeutic strategies.
- Further research into the specific mechanisms of enteric nervous system dysfunction in constipation is warranted.
- Understanding the organic basis of functional gastrointestinal disorders will improve patient outcomes.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...